Wortham L*

SeraSeal Owner and Manufacturer, Primary Hemostatic agent SeraSeal, India

*Corresponding Author: Wortham L, SeraSeal Owner and Manufacturer, Primary Hemostatic agent SeraSeal, India.

Received: October 09, 2024; Published:April 23, 2025

Abstract

SeraSeal is a topical primary hemostatic agent designed to arrest venous, arterial, and bone marrow hemorrhages and all four classes of hemorrhages, even in the presence of coagulopathies, within seconds. The active agents in SeraSeal: agar, bovine FIIa, FVIIa, FIXa, FXa, achieve hemostasis within seconds by catalyzing the normal coagulation cascade system that has been activated by the release of A major multicenter clinical study of SeraSeal vs cauterization as a primary [1,2] thromboplastin from the injured tissue. Bleeding is a major cause of morbidity and mortality in wounds. Hemorrhage is responsible for 30–40% of trauma mortality, and of those deaths, 33–56% occur during the prehospital period. Among those who reach hospital care, early mortality is caused by continued hemorrhage, coagulopathy, and incomplete resuscitation. Treatment of acute hemorrhage outside and inside the clinical setting with SeraSeal will reduce the trauma morbidity rate. hemostatic agent, was conducted on a wide range of tissues that significantly outperformed cauterization by achieving hemostasis more than 25% faster.

Keywords:Sera Seal; Primary; Hemostatic; Agent

References

1. Kauvar DS., et al. “Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations”. Journal of Trauma 60.6  (2006): S3-11.
2. Shackelford S and Eastridge B. “Epidemiology of prehospital and hospital traumatic deaths from life-threatening hemorrhage (2012).
3. Schaefer R. “Every Minute Matters in Hemorrhagic Shock. White Paper (2012).
4. Hooper N and Armstrong TJ. “Hemorrhagic shock (2012).
5. Karn A. “Hemorrhagic shock” (2012).
6. Nora Eccles Harrison Cardiovascular Research and Training Institute.
7. Dries DJ. “Hypovolemic and traumatic shock: nonsurgical management. In: and severe hemorrhage: role of hepatic 11β-hydroxysteroid dehydrogenase. Parillo JE, Dellinger RP. “Critical Care Medicine: Principles of Diagnosis and Management in the Adult. 5^th edition. Philadelphia, PA: Elsevier (2019).
8. Quintana EN., et al. “Acute cardiogenic shock secondary to blunt traumatic aortic valve injury”. Trauma Case Reports 51 (2024): 100995.
9. Seymour CW., et al. “Time to treatment and mortality during mandated emergency care for sepsis”. The New England Journal of Medicine (2024).
10. Wang P., et al. “Mechanism of adrenal insufficiency following trauma”. Archives of Surgery 134.4 (1999): 394-401.
11. Bougle A., et al. “Resuscitative strategies in traumatic hemorrhagic shock”. Annals of Intensive Care 3.1 (2013): 1.
12. Subeg Y., et al. “Hypothermia caused by slow and limited-volume fluid resuscitation decreases organ damage by hemorrhagic shock”. Cytokine 60.4 (2012): 68-75.
13. Balmaceda A., et al. “Resuscitation from a pH of 6.5: A case report and review of pathophysiological and management of extreme acidosis from hypovolemic shock after trauma”. Journal of Trauma and Injury 32.4 (2019): 238-242.
14. Dodson GP. “Trauma of major surgery: A global problem that is not going away”. International Journal of Surgery 81 (2020): 47-54.
15. Dodson GP., et al. “Traumatic induced coagulopathy as a systems failure: A new window into hemostasis”. Seminars in Thrombosis and Hemostasis 46.2 (2020): 199-214.
16. Neylan T and O’Donovan A. “Inflammation and PTSD”. PTSD Research Quarterly (2019).
17. Wortham L. “A Multi-Center, Single Blinded, Parallel, Randomized, Hemostatic Agent Clinical Study. Wortham Laboratories, Inc., WLI Document Number: WLI1196-PER (2004).

Citation

Citation: Wortham L. “SeraSeal, a Topical Primary Hemostatic Agent".Acta Scientific Gastrointestinal Disorders 8.5 (2025): 23-24.

Copyright

Copyright: © 2025 Wortham L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.